Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PRAD | rs12292117 | chr11:24216739 | C/A | 5.2E-9 | 494 | 30.8 | 37.47 | 22.92 | KM Plot |
PRAD | rs12292949 | chr11:72457531 | C/T | 5.24E-5 | 480 | 30.53 | 33.88 | 21.9 | KM Plot |
PRAD | rs12293592 | chr11:24224433 | A/C | 6.29E-5 | 492 | 30.73 | 38.65 | 24.9 | KM Plot |
PRAD | rs12294118 | chr11:24212083 | C/T | 2.94E-8 | 493 | 30.97 | 31.4 | 20.93 | KM Plot |
PRAD | rs12301300 | chr12:768377 | C/T | 7.44E-5 | 492 | 31.03 | 31 | 29.17 | KM Plot |
PRAD | rs12303868 | chr12:768367 | A/G | 7.44E-5 | 492 | 31.03 | 31 | 29.17 | KM Plot |
PRAD | rs12307171 | chr12:768874 | C/T | 0.000124 | 494 | 28.87 | 31.23 | 31.13 | KM Plot |
PRAD | rs1230946 | chr16:3407682 | C/G | 1.52E-5 | 494 | 26.37 | 35.47 | 28.8 | KM Plot |
PRAD | rs12339187 | chr9:137229327 | C/T | 1.22E-5 | 494 | 29.22 | 28.57 | 32.5 | KM Plot |
PRAD | rs12353112 | chr9:133765872 | A/G | 5.9E-5 | 494 | 20.93 | 33.07 | 30.75 | KM Plot |
PRAD | rs12354763 | chr10:131791132 | C/T | 7.21E-6 | 476 | 32 | 29.1 | 26.37 | KM Plot |
PRAD | rs12357082 | chr10:99402378 | C/A | 5.76E-6 | 492 | 31.27 | 29.13 | 24.67 | KM Plot |
PRAD | rs12360261 | chr10:94783360 | A/G | 0.000134 | 485 | 30.23 | 32.5 | 59.8 | KM Plot |
PRAD | rs12369036 | chr12:731402 | C/T | 0.000148 | 490 | 31.33 | 28.13 | 22.67 | KM Plot |
PRAD | rs12372925 | chr15:82562506 | T/C | 8.97E-6 | 478 | 30.12 | 36.47 | 36.65 | KM Plot |